Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BMY compared with ABBV: revenue, margins and what each company keeps, and the suppliers and customers both name
BMY
Bristol Myers Squibb Co
Change
Mkt cap
Revenue
Revenue
ABBV
AbbVie Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BMY
Bristol Myers Squibb Co
vs
ABBV
AbbVie Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
BMY
1 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±3.6%
▲
+1.35%
×0.39
Q2 FY26
±3.7%
▲
+2.79%
×0.76
Q1 FY26
±4.1%
▲
+5.21%
×1.27
Feb 5 '26
±3.8%
▲
+3.30%
×0.87
ABBV
0 of 4
at or beyond implied
Report
implied
realized
× implied
Oct 30 '26
±3.5%
▲
+1.41%
×0.40
Q2 FY26
±3.5%
▼
−2.51%
×0.71
= implied
BMY realized, solid
ABBV realized, hatched
One scale, both sides: full bar = 6%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±4.0%
▲
+3.14%
×0.78
Feb 4 '26
±3.9%
▼
−3.79%
×0.97
BMY
Bristol Myers Squibb Co
Change
62.52
▲
+1.85%
· post 62.55
Mkt cap
$127.7B
Revenue
$13.1B
Q3 FY26
Revenue
$48.2B
FY25
ABBV
AbbVie Inc.
Change
293.92
▲
+1.08%
· post 294.99
Closed
Oct 30 '26
Mkt cap
$521.1B
Revenue
$17.0B
Q2 FY26
Revenue
$61.2B
FY25
vs
Compare
Closed
Oct 30 '26
BMY
Bristol Myers Squibb Co
vs
ABBV
AbbVie Inc.
62.52
▲
+1.85%
post 62.55
Price
293.92
▲
+1.08%
post 294.99
$127.7B
Mkt cap
$521.1B
Q3 FY26
$13.1B
Revenue
$17.0B
Q2 FY26
FY25
$48.2B
Revenue
$61.2B
FY25
Change
Change
BMY
62.52
▲
+1.85%
vs
ABBV
293.92
▲
+1.08%
Closed
Oct 30 '26